Cyclic AMP Is an Essential Factor in Immune Responses

In the present studies, cAMP, a secondary messenger historically viewed as a negative mediator of immune responses, was demonstrated to possess immunoenhancing activity at low concentrations. In parallel experiments the adenylate cyclase inhibitor, 2′,3′-dideoxyadenosine, produced a marked inhibitio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 1995-01, Vol.206 (2), p.703-709
Hauptverfasser: Koh, W.S., Yang, K.H., Kaminski, N.E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 709
container_issue 2
container_start_page 703
container_title Biochemical and biophysical research communications
container_volume 206
creator Koh, W.S.
Yang, K.H.
Kaminski, N.E.
description In the present studies, cAMP, a secondary messenger historically viewed as a negative mediator of immune responses, was demonstrated to possess immunoenhancing activity at low concentrations. In parallel experiments the adenylate cyclase inhibitor, 2′,3′-dideoxyadenosine, produced a marked inhibition of humoral and proliferative immune responses suggesting that cAMP at physiologically relavent concentrations acts as a critical second messenger in immune responses. Direct addition of dibutyryl cAMP (10 - 100 μM), a membrane permeable cAMP analog, to mouse spleen cell cultures produced a marked and dose-related increase (25-100%) in humoral immune responses as measured by the primary IgM antibody forming cell response to the antigen, sheep erythrocytes. Over a similar concentration range, dibutyryl cAMP (5 - 50 μM) also dose-dependently enhanced (25-50%) phorbol 12-myristate 13-acetate/ionomycin-stimulated lymphoproliferation. Incubation of spleen cells with 2′,3′-dideoxyadenosine (40 - 80 μM), an adenylate cyclase inhibitor, for 30 min depressed significantly the basal level of intracellular cAMP. 2′,3′-dideoxyadenosine treatment also significantly decreased both the antibody forming cell response and the proliferative response in a dose-dependent manner. Interestingly, the antibody forming cell response exhibited significantly greater sensitivity to inhibition by 2′,3′-dideoxyadenosine than the lymphoproliferative responses. The critical role for cAMP as a positive immunoregulatory signal is further supported by the fact that the immunosuppression by 2′,3′-dideoxyadenosine could be reversed completely in the antibody forming cell response to sheep erythrocytes through the addition of dibutyryl cAMP into the culture medium. Partial but not complete reversal of the inhibitory effects of 2′,3′-dideoxyadenosine on lymphoproliferation was also demonstrated by dibutyryl cAMP. Taken together, these results suggest that cAMP acts as a positive regulatory signal for immune responses as indicated by the fact that depletion of intracellular cAMP induces a marked inhibition of humoral and proliferative responses.
doi_str_mv 10.1006/bbrc.1995.1099
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1006_bbrc_1995_1099</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X85710996</els_id><sourcerecordid>S0006291X85710996</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-d4705da853f7391b51ff4078d2bfb930e5db65dbea3ec372446b8c1e97df023e3</originalsourceid><addsrcrecordid>eNp1j81LAzEQxYMotVav3oT8A1snm_3KsZRWCxVFFLyFfEwg0t0tyVbof2-WFm8ehscw7z3mR8g9gzkDqB61DmbOhCjTKsQFmSaBLGdQXJIpJEeWC_Z1TW5i_AZgrKjEhEzqJq-4gCkpl0ez84YuXt7oJlLV0VWM2A1e7ehamaEP1Hd007aHDuk7xn3fRYy35MqpXcS7s87I53r1sXzOtq9Pm-VimxnOxZDZoobSqqbkruaC6ZI5V0Dd2Fw7LThgaXWVBhVHw-u8KCrdGIaitg5yjnxG5qdeE_oYAzq5D75V4SgZyBFfjvhyxJcjfgo8nAL7g27R_tnPvOnenO6Yvv7xGGQ0HjuD1gc0g7S9_6_6F3gpaBs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cyclic AMP Is an Essential Factor in Immune Responses</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Koh, W.S. ; Yang, K.H. ; Kaminski, N.E.</creator><creatorcontrib>Koh, W.S. ; Yang, K.H. ; Kaminski, N.E.</creatorcontrib><description>In the present studies, cAMP, a secondary messenger historically viewed as a negative mediator of immune responses, was demonstrated to possess immunoenhancing activity at low concentrations. In parallel experiments the adenylate cyclase inhibitor, 2′,3′-dideoxyadenosine, produced a marked inhibition of humoral and proliferative immune responses suggesting that cAMP at physiologically relavent concentrations acts as a critical second messenger in immune responses. Direct addition of dibutyryl cAMP (10 - 100 μM), a membrane permeable cAMP analog, to mouse spleen cell cultures produced a marked and dose-related increase (25-100%) in humoral immune responses as measured by the primary IgM antibody forming cell response to the antigen, sheep erythrocytes. Over a similar concentration range, dibutyryl cAMP (5 - 50 μM) also dose-dependently enhanced (25-50%) phorbol 12-myristate 13-acetate/ionomycin-stimulated lymphoproliferation. Incubation of spleen cells with 2′,3′-dideoxyadenosine (40 - 80 μM), an adenylate cyclase inhibitor, for 30 min depressed significantly the basal level of intracellular cAMP. 2′,3′-dideoxyadenosine treatment also significantly decreased both the antibody forming cell response and the proliferative response in a dose-dependent manner. Interestingly, the antibody forming cell response exhibited significantly greater sensitivity to inhibition by 2′,3′-dideoxyadenosine than the lymphoproliferative responses. The critical role for cAMP as a positive immunoregulatory signal is further supported by the fact that the immunosuppression by 2′,3′-dideoxyadenosine could be reversed completely in the antibody forming cell response to sheep erythrocytes through the addition of dibutyryl cAMP into the culture medium. Partial but not complete reversal of the inhibitory effects of 2′,3′-dideoxyadenosine on lymphoproliferation was also demonstrated by dibutyryl cAMP. Taken together, these results suggest that cAMP acts as a positive regulatory signal for immune responses as indicated by the fact that depletion of intracellular cAMP induces a marked inhibition of humoral and proliferative responses.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1006/bbrc.1995.1099</identifier><identifier>PMID: 7826390</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Antibody Formation - drug effects ; B-Lymphocytes - drug effects ; B-Lymphocytes - immunology ; Bucladesine - pharmacology ; Cells, Cultured ; Cyclic AMP - physiology ; Dideoxyadenosine - pharmacology ; Dose-Response Relationship, Drug ; Female ; Ionomycin - pharmacology ; Lymphocyte Activation - drug effects ; Mice ; Mice, Inbred Strains ; Second Messenger Systems ; Spleen - immunology ; Tetradecanoylphorbol Acetate - pharmacology</subject><ispartof>Biochemical and biophysical research communications, 1995-01, Vol.206 (2), p.703-709</ispartof><rights>1995 Academic Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-d4705da853f7391b51ff4078d2bfb930e5db65dbea3ec372446b8c1e97df023e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/bbrc.1995.1099$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7826390$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koh, W.S.</creatorcontrib><creatorcontrib>Yang, K.H.</creatorcontrib><creatorcontrib>Kaminski, N.E.</creatorcontrib><title>Cyclic AMP Is an Essential Factor in Immune Responses</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>In the present studies, cAMP, a secondary messenger historically viewed as a negative mediator of immune responses, was demonstrated to possess immunoenhancing activity at low concentrations. In parallel experiments the adenylate cyclase inhibitor, 2′,3′-dideoxyadenosine, produced a marked inhibition of humoral and proliferative immune responses suggesting that cAMP at physiologically relavent concentrations acts as a critical second messenger in immune responses. Direct addition of dibutyryl cAMP (10 - 100 μM), a membrane permeable cAMP analog, to mouse spleen cell cultures produced a marked and dose-related increase (25-100%) in humoral immune responses as measured by the primary IgM antibody forming cell response to the antigen, sheep erythrocytes. Over a similar concentration range, dibutyryl cAMP (5 - 50 μM) also dose-dependently enhanced (25-50%) phorbol 12-myristate 13-acetate/ionomycin-stimulated lymphoproliferation. Incubation of spleen cells with 2′,3′-dideoxyadenosine (40 - 80 μM), an adenylate cyclase inhibitor, for 30 min depressed significantly the basal level of intracellular cAMP. 2′,3′-dideoxyadenosine treatment also significantly decreased both the antibody forming cell response and the proliferative response in a dose-dependent manner. Interestingly, the antibody forming cell response exhibited significantly greater sensitivity to inhibition by 2′,3′-dideoxyadenosine than the lymphoproliferative responses. The critical role for cAMP as a positive immunoregulatory signal is further supported by the fact that the immunosuppression by 2′,3′-dideoxyadenosine could be reversed completely in the antibody forming cell response to sheep erythrocytes through the addition of dibutyryl cAMP into the culture medium. Partial but not complete reversal of the inhibitory effects of 2′,3′-dideoxyadenosine on lymphoproliferation was also demonstrated by dibutyryl cAMP. Taken together, these results suggest that cAMP acts as a positive regulatory signal for immune responses as indicated by the fact that depletion of intracellular cAMP induces a marked inhibition of humoral and proliferative responses.</description><subject>Animals</subject><subject>Antibody Formation - drug effects</subject><subject>B-Lymphocytes - drug effects</subject><subject>B-Lymphocytes - immunology</subject><subject>Bucladesine - pharmacology</subject><subject>Cells, Cultured</subject><subject>Cyclic AMP - physiology</subject><subject>Dideoxyadenosine - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>Ionomycin - pharmacology</subject><subject>Lymphocyte Activation - drug effects</subject><subject>Mice</subject><subject>Mice, Inbred Strains</subject><subject>Second Messenger Systems</subject><subject>Spleen - immunology</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1j81LAzEQxYMotVav3oT8A1snm_3KsZRWCxVFFLyFfEwg0t0tyVbof2-WFm8ehscw7z3mR8g9gzkDqB61DmbOhCjTKsQFmSaBLGdQXJIpJEeWC_Z1TW5i_AZgrKjEhEzqJq-4gCkpl0ez84YuXt7oJlLV0VWM2A1e7ehamaEP1Hd007aHDuk7xn3fRYy35MqpXcS7s87I53r1sXzOtq9Pm-VimxnOxZDZoobSqqbkruaC6ZI5V0Dd2Fw7LThgaXWVBhVHw-u8KCrdGIaitg5yjnxG5qdeE_oYAzq5D75V4SgZyBFfjvhyxJcjfgo8nAL7g27R_tnPvOnenO6Yvv7xGGQ0HjuD1gc0g7S9_6_6F3gpaBs</recordid><startdate>19950117</startdate><enddate>19950117</enddate><creator>Koh, W.S.</creator><creator>Yang, K.H.</creator><creator>Kaminski, N.E.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19950117</creationdate><title>Cyclic AMP Is an Essential Factor in Immune Responses</title><author>Koh, W.S. ; Yang, K.H. ; Kaminski, N.E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-d4705da853f7391b51ff4078d2bfb930e5db65dbea3ec372446b8c1e97df023e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Animals</topic><topic>Antibody Formation - drug effects</topic><topic>B-Lymphocytes - drug effects</topic><topic>B-Lymphocytes - immunology</topic><topic>Bucladesine - pharmacology</topic><topic>Cells, Cultured</topic><topic>Cyclic AMP - physiology</topic><topic>Dideoxyadenosine - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>Ionomycin - pharmacology</topic><topic>Lymphocyte Activation - drug effects</topic><topic>Mice</topic><topic>Mice, Inbred Strains</topic><topic>Second Messenger Systems</topic><topic>Spleen - immunology</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koh, W.S.</creatorcontrib><creatorcontrib>Yang, K.H.</creatorcontrib><creatorcontrib>Kaminski, N.E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koh, W.S.</au><au>Yang, K.H.</au><au>Kaminski, N.E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cyclic AMP Is an Essential Factor in Immune Responses</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>1995-01-17</date><risdate>1995</risdate><volume>206</volume><issue>2</issue><spage>703</spage><epage>709</epage><pages>703-709</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>In the present studies, cAMP, a secondary messenger historically viewed as a negative mediator of immune responses, was demonstrated to possess immunoenhancing activity at low concentrations. In parallel experiments the adenylate cyclase inhibitor, 2′,3′-dideoxyadenosine, produced a marked inhibition of humoral and proliferative immune responses suggesting that cAMP at physiologically relavent concentrations acts as a critical second messenger in immune responses. Direct addition of dibutyryl cAMP (10 - 100 μM), a membrane permeable cAMP analog, to mouse spleen cell cultures produced a marked and dose-related increase (25-100%) in humoral immune responses as measured by the primary IgM antibody forming cell response to the antigen, sheep erythrocytes. Over a similar concentration range, dibutyryl cAMP (5 - 50 μM) also dose-dependently enhanced (25-50%) phorbol 12-myristate 13-acetate/ionomycin-stimulated lymphoproliferation. Incubation of spleen cells with 2′,3′-dideoxyadenosine (40 - 80 μM), an adenylate cyclase inhibitor, for 30 min depressed significantly the basal level of intracellular cAMP. 2′,3′-dideoxyadenosine treatment also significantly decreased both the antibody forming cell response and the proliferative response in a dose-dependent manner. Interestingly, the antibody forming cell response exhibited significantly greater sensitivity to inhibition by 2′,3′-dideoxyadenosine than the lymphoproliferative responses. The critical role for cAMP as a positive immunoregulatory signal is further supported by the fact that the immunosuppression by 2′,3′-dideoxyadenosine could be reversed completely in the antibody forming cell response to sheep erythrocytes through the addition of dibutyryl cAMP into the culture medium. Partial but not complete reversal of the inhibitory effects of 2′,3′-dideoxyadenosine on lymphoproliferation was also demonstrated by dibutyryl cAMP. Taken together, these results suggest that cAMP acts as a positive regulatory signal for immune responses as indicated by the fact that depletion of intracellular cAMP induces a marked inhibition of humoral and proliferative responses.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>7826390</pmid><doi>10.1006/bbrc.1995.1099</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-291X
ispartof Biochemical and biophysical research communications, 1995-01, Vol.206 (2), p.703-709
issn 0006-291X
1090-2104
language eng
recordid cdi_crossref_primary_10_1006_bbrc_1995_1099
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Animals
Antibody Formation - drug effects
B-Lymphocytes - drug effects
B-Lymphocytes - immunology
Bucladesine - pharmacology
Cells, Cultured
Cyclic AMP - physiology
Dideoxyadenosine - pharmacology
Dose-Response Relationship, Drug
Female
Ionomycin - pharmacology
Lymphocyte Activation - drug effects
Mice
Mice, Inbred Strains
Second Messenger Systems
Spleen - immunology
Tetradecanoylphorbol Acetate - pharmacology
title Cyclic AMP Is an Essential Factor in Immune Responses
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T23%3A35%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cyclic%20AMP%20Is%20an%20Essential%20Factor%20in%20Immune%20Responses&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Koh,%20W.S.&rft.date=1995-01-17&rft.volume=206&rft.issue=2&rft.spage=703&rft.epage=709&rft.pages=703-709&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1006/bbrc.1995.1099&rft_dat=%3Celsevier_cross%3ES0006291X85710996%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/7826390&rft_els_id=S0006291X85710996&rfr_iscdi=true